The present study evaluated 5 of the 8 main TP53 mutation hot spots in cancer by restriction site mutation analysis and compared the results with p53 protein expression in patients with cancer of the tongue. Tumor samples from 49 patients with tongue cancer were screened for TP53 mutations in exons 5 through 8 by PCR restriction site mutation analysis and for p53 protein expression by immunohistochemistry using the DO-7 antibody. Nuclear accumulation of p53 protein was seen in 22% (11/49) of the tumors, whereas none of the patients exhibited TP53 mutations in exons 5 through 8. The observed data suggest that TP53 mutations alone are not responsible for abnormal accumulation of p53 protein in tobacco-chewing-mediated tongue carcinogenesis.
LevineA.P53, the cellular gatekeeper for growth and division.Cell1997; 88: 323–31.
2.
HollsteinM., RiceK., GreenblattM.S.Database of p53 somatic mutations in human tumors and cell lines.Nucl Acids Res1994; 22: 3551–5.
3.
GreenblattM.S., BennettW.P., HollsteinM., HarrisC.C.Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Cancer Res1994; 54: 4855–78.
4.
Raybaud-DiogèneH., TétuB., MorencyR., FortinA., MonteilR.A.p53 over-expression in head-and-neck squamous-cell carcinomas: review of the literature.Eur J Cancer B Oral Oncol1996; 32B: 143–9.
5.
SzymañskaK., HainautP.TP53 and mutations in human cancer.Acta Biochim Pol2003; 50: 231–8.
6.
LazarusP., SternJ., ZwiebelN.Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use.Carcinogenesis1996; 17: 733–9.
7.
SomersK.D., MerrickM.A., LopezM.E.Frequent p53 mutations in head and neck cancer.Cancer Res1992; 52: 5997–6000.
8.
CruzI., SnijdersP.J.F., HoutenV.V.Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.J Clin Pathol2002; 55: 834–40.
9.
WongY.K., LiuT.Y., ChangK.W.p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan.J Oral Pathol Med1998; 27: 243–8.
10.
Acha-SagredoA., RuesgaM.T., RodriguezC.p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.Oral Oncol2009; 45: 661–4.
11.
RalhanR., AgarwalS., NathN.Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.Oral Oncology2001; 37: 243–50.
12.
RanasingheA., MacGeochC., DyerS.Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5–9.Anticancer Res1993; 13: 2065–8.
13.
ThomasS., BrennanJ., MartelG.Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea.Cancer Res1994; 54: 3588–93.
14.
BartenM., OstwaldC., Milde-LangoschK.HPV DNA and p53 alterations in oropharyngeal carcinomas.Virchows Arch1995; 427: 153–7.
15.
XuJ., Gimenez-ContiI.B., CunninghamJ.E.Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use.Cancer1998; 83: 204–12.
16.
MinetaH., BorgA., DictorM.p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.Br J Cancer1998; 78: 1084–90.
17.
KuoM.Y., HuangJ.S., HsuH.C.Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan.J Oral Pathol Med1999; 28: 221–5.
18.
SaranathD., TandleA.T., TeniT.R.p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.Oral Oncol1999; 35: 242–50.
19.
HogmoA., Borresen-DaleA.L., BlegenH.TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.Anticancer Res1999; 19: 3433–8.
20.
GanlyI., SoutarD.S., BrownR., KayeS.B.P53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.Br J Cancer2000; 82: 392–8.
21.
OgmundsdottirH.M., BjornssonJ., HolbrookW.P.Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.J Oral Pathol Med2009; 38: 565–71.
22.
SmardovaJ., KsicovaK., BinkovaH.Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.Oncol Rep2004; 11: 923–9.
23.
FieldJ.K., SpandidosD.A., MalliriA.Elevated p53 expression correlates with a history of heavy smoking in squamous-cell carcinoma of the head and neck.Br J Cancer1991; 64: 573–7.
24.
FieldJ.K., ZoumpourlisV., SpandidosD.A., JonesA.S.p53 expression and mutations in squamous-cell carcinoma of the head and neck: expression correlates with the patient's use of tobacco and alcohol.Cancer Detect Prev1994; 18: 197–208.
25.
BrennanJ.A., BoyleJ.O., KochW.M.Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.N Engl J Med1995; 332: 712–7.
26.
LazarusP., IdrisA.M., KimJ., CalcagnottoA., HoffmannD.p53 mutations in head-and-neck squamous-cell carcinomas from Sudanese snuff (toombak) users.Cancer Detect Prev1996; 20: 270–8.
27.
KaurJ., SrivastavaA., RalhanR.Over-expression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.Int J Cancer1994; 58: 340–5.
28.
VoraH.H., TrivediT.I., ShahN.G.p53 expression in leukoplakia and carcinoma of the tongue.Int J Biol Markers2006; 21: 74–80.
29.
JenkinsG.J.S., DoakS.H., GriffithsA.P.Early p53 mutations in non-dysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology.Br J Cancer2003; 88: 1271–6.
30.
JenkinsG.J.S., WilliamsG.L., BeynonJ.Restriction enzymes: a molecular tool for analysing the genetic alterations in cancer progression.Br J Surg2001; 89: 8–20.
31.
JenkinsG.J.S., MorganC., ParryE.M.The detection of mutations induced in vitro in the human p53 gene by hydrogen peroxide with the restriction site mutation (RSM) assay.Mutat Res2001; 498: 135–44.
PillaiG., RobertsH., GatterK., PezzellaF.p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems.Histopathology2003; 42: 83–7.
34.
BattiforaH.p53 immunohistochemistry: a word of caution.Hum Pathol1994, 25: 435–7.
35.
CoggiG., BosariS., RonacalliM.P53 protein accumulation and p53 gene mutation in esophageal carcinoma.Cancer1997; 79: 425–32.
36.
MunirajanA.K., Tutsumi-IshiiY., MohanprasadB.K.C.p53 gene mutations in oral carcinomas from India.Int J Cancer1996; 66: 297–300.
37.
SakaiE., RikimaruK., UedaM.The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma.Int J Cancer1992; 52: 867–72.
38.
AtulaS., KurvinenK., GrenmanR.SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer.Eur J Cancer B Oral Oncol1996; 32B: 222–9.
39.
AhomadegbeJ.C., BarroisM., FogelS.High incidence of p53 alterations in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.Oncogene1995; 10: 1217–27.
40.
PatnaikS., NayakB.K., DasB.R.Genetic alteration of p53 in oral tumors. In: VarmaA.K., ed. Oral oncology, Vol. VI. New Delhi, India: Macmillan India Limited, 1999; 87–92.
41.
TsurusakoS.I., TanakaH., HayashiY.Low incidence of p53 mutations in well-differentiated tongue squamous cell carcinoma in Japan.Jap J Clin Oncol2002; 32: 327–31.
42.
SoussiT., KatoS., LevyP.P., IshiokaC.Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations.Hum Mutat2005; 25: 6–17.
43.
PoetaM.L., ManolaJ., GoldwasserM.A.TP53 mutations and survival in squamous cell carcinoma of the head and neck.N Engl J Med2007; 357: 2552–61.
44.
KuT.K., NguyenD.C., KaramanM., GillP., HaciaJ.G., CroweD.L.Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.Mol Cancer Res2007; 5: 351–62.
45.
OffnerS., SchmausW., WitterK.p53 gene mutations are not required for early dissemination of cancer cells.Proc Natl Acad Sci U S A1999; 96: 6942–6.
